Viewing Study NCT03017560


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-30 @ 10:19 AM
Study NCT ID: NCT03017560
Status: COMPLETED
Last Update Posted: 2023-11-07
First Post: 2017-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer
Sponsor: Northwestern University
Organization:

Study Overview

Official Title: Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer
Status: COMPLETED
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary purpose of this study is to test the effects of a targeted, computerized cognitive training program on verbal memory in older women who have undergone chemotherapy treatment for early-stage breast cancer. As measured by neuropsychological assessment, this treatment will result in improved verbal memory. Secondarily, processing speed and naming abilities are expected to improve. Enhanced self-perception of cognitive ability is also expected.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: